NCT06836518Not yet recruiting
Sialic Acid in Hepatocellular Carcinoma
Serum Sialic Acid as a Novel Biomarker in the Diagnosis of Hepatocellular Carcinoma
Source: ClinicalTrials.gov · Last updated 20 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Hepatocellular carcinoma (HCC) accounts for approximately 90% of the cases of liver cancer and is associated with high morbidity and mortality. The increased sialic acids(SAs) in tumor cells are mainly caused by the special metabolic flux and aberrant expression of sialyltransferases/sialidases, The high sensitivity of sialic acids in or plasma as a tumor marker has been reported in various cancerous conditions the level of sialic acid(SA) activity was found to offer highly specific and sensitive tumor biomarker for diagnosis and follow up of HCC post-therapy.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 14 Feb 2025
- Start date
- 1 Mar 2025
- Primary completion date
- 1 Mar 2026
- Lead sponsor
- Sohag University
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT06836518
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Mar 2025 to the primary completion date, 1 Mar 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- 1- Patients aged \< 18 or \> 70 years. 2- Patients with other malignancy rather than HCC. 3- Patients with history of prior intervention or systemic chemotherapy for HCC.
Who the study is looking for
- The study will include normal persons, patients with liver cirrhosis and HCC patients attending to the outpatient clinic or inpatient section of the department of Tropical medicine and Gastroenterology and Radiological department at Sohag University Hospital will be included.
Age in the registry: 18 years to 70 years · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.